Stock comparison
Anteris Technologies Global
AVR$802.1MHealthcare Market cap, Sector
Pro Medicus Limited
PME.AX$16.79BHealthcare Market cap, Sector
Overall winner
Pro Medicus Limited
AVR 07 PME.AX
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
Fit scores by strategy
AVR0wins
7winsPME.AX
25F
B78
23F
A90
31F
A98
0F
A100
0F
B84
30F
A91
30F
A96
Side-by-side metrics
| Metric | AVR | PME.AX |
|---|---|---|
| Market cap | $802.1M | $16.79B Winner |
| P/E (TTM) | Winner: - | 147.6x |
| EV/EBIT | Winner: - | 106.8x |
| ROIC (TTM) | -34.04% | 42.56% Winner |
| Gross margin | 28.25% | 99.85% Winner |
| Net margin | -51.49% | 54.12% Winner |
| Revenue CAGR 5y | -24.32% | 31.61% Winner |
| EPS CAGR 5y | - | 37.34% |
| Debt / Equity | 0.0x | 0.0x Winner |
| Dividend yield | 0.0% | - |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
AVR leads on
- P/E (TTM)-vs 147.6x+101%
- EV/EBIT-vs 106.8x+100%
PME.AX leads on
- ROIC (TTM)42.56%vs -34.04%+180%
- Revenue CAGR 5y31.61%vs -24.32%+177%
- Net margin54.12%vs -51.49%+101%
- Market cap$16.79Bvs $802.1M+95%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.